Le Lézard
Classified in: Health
Subjects: NPT, PDT

ConsumerMedical and Medica Partner to Expand Members' Healthcare Services


PEMBROKE, Mass., Jan. 14, 2019 /PRNewswire/ -- ConsumerMedical has announced that Medica, a prominent nonprofit health services company, has selected ConsumerMedical to provide members independent clinical guidance for making smarter healthcare decisions.

ConsumerMedical celebrates its 20th anniversary with evolutionary new branding. (PRNewsFoto/ConsumerMedical)

"We want to ensure our members have the best support possible as they navigate the health care system, that they understand their diagnosis and the treatment options available to them as well as how to find the very best physicians and hospitals in our network," says Dr. John Piatkowski, senior medical director at Medica.

 ConsumerMedical, a leading clinical advocacy, decision support, and expert second opinion company, already serves over 3 million individuals through some of the nation's largest employers, health plans, and private exchanges.  An early pioneer in the growing field of healthcare advocacy, ConsumerMedical's 23 years of experience has driven unique offering centered around today's healthcare consumer's evolving needs.  ConsumerMedical recently announced enhanced support for two of today's most complex and costly conditions effecting American families:  behavioral health and oncology.  

"At ConsumerMedical we work diligently to ensure that every consumer that uses our services has the right diagnosis, the right treatment by the right provider and gets all the follow up support they need, no matter what their medical condition," says Kevin Kickhaefer, President of ConsumerMedical. "We know that is very well aligned with Medica's Vision: to be trusted in the community for their unwavering commitment to high-quality, affordable health care."

ConsumerMedical's programs provide proven results.  Eighty-eight percent of consumers experience better clinical outcomes after using their market-leading services.  Independent research also consistently shows that ConsumerMedical offerings delivers provider customers with an average return of $4 saved for every $1 invested in the program.  

ConsumerMedical services are available for eligible members of Medica group plans beginning January 1, 2019.

About ConsumerMedical
ConsumerMedical is a leading clinical advocacy, decision support and expert second opinion company serving over 3 million individuals through some of the nation's largest employers, health plans and private exchanges. The company has been serving patients and payers for over 23 years. As a Medical Ally, ConsumerMedical guides participants throughout their healthcare journey with compassionate, high-touch support and deep clinical expertise. ConsumerMedical offers a fully integrated suite of solutions including Medical Decision Support, Surgery Decision Support, Expert Medical Opinion, Claims Advocacy and more, helping individuals and families navigate the healthcare system while improving outcomes and reducing costs. ConsumerMedical's results have been validated continuously by independent actuaries.

About Medica
Medica (medica.com) is a non-profit health plan headquartered in Minneapolis. The company serves communities in the heart of America by providing health care coverage and related services in the employer, individual, Medicaid and Medicare markets. It operates in Minnesota, Iowa, Kansas, Missouri, Nebraska, North Dakota, Oklahoma, South Dakota and Wisconsin. Medica also offers national network coverage to employers who have employees outside the Medica regional network.

Medica's vision is to be trusted in the community for our unwavering commitment to high quality, affordable health care. Medica's annual report, which includes the organization's community involvement activities, is available online.

 

SOURCE ConsumerMedical


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: